Skip to main content

Table 4 Treatments for HCC recurrence

From: C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion

 

Recurrence

 

Treatments on recurrence

HCC with PV invasion (n=67)

HCC without PV invasion (n=410)

P value

Liver resection

0 (0%)

18 (4.4%)

0.091

Liver transplantation

3 (4.5%)

7 (1.7%)

0.154

RFA

6 (9.0%)

125 (30.5%)

<0.001

TACE

39 (58.2%)

242 (59.0%)

0.894

Sorafenib

12 (17.9%)

67 (16.3%)

0.725

Radiation

9 (13.4%)

42 (10.2%)

0.400

Chemotherapy

5 (7.5%)

23 (5.6%)

0.573

  1. RFA, Radiofrequency ablation; TACE, Transarterial chemoembolization.